Korean Tickers
KRX in English
HomeMarketsStocksFinancialsGuide
NewsfeedInsightsEarningsBroker research
AI Value Chain
X
Korean Tickers
KRX in English
HomeMarketsStocksFinancialsGuide
NewsfeedInsightsEarningsBroker research
AI Value Chain
XSign in

Market Pulse

Daily · Nov 5, 2026 · data.go.kr + ECOS
KOSPI
5,383.80
-300.00 (-5.28%)
KOSDAQ
678.41
-36.54 (-5.11%)
KOSPI 200
837.78
-51.47 (-5.79%)
USD/KRW
1,342.10
Home›Reports›000100
000100KOSPI·Jul 31, 2026

Lazcluze uptake likely to accelerate; growing out-licensing potential

YUHAN CORPORATIONMirae Asset SecuritiesSeung-min Kim
Read original PDF ↗
Source
Mirae Asset Securities
Type
Company Analysis
Language
English
Rating
Buy
Target price
-
Collected
Sep 14, 2026
The full report is published by Mirae Asset Securities. Korean Tickers provides its source link and metadata.

More research on 000100

Lazertinib royalty growth disappoints; out-licensing potential remainsMirae Asset Securities · Oct 29, 2026Initiating Coverage: Royalties Should Begin in EarnestKB Securities · May 27, 2026Focus on pace of lazertinib growth and out-licensing potentialMirae Asset Securities · Feb 12, 2026Excluding Base Effects, Results SolidKB Securities · Nov 06, 2025API exports and licensing income drive earnings surpriseMirae Asset Securities · Jul 31, 2025Earnings miss due to absence of milestone income, but API growth stands outMirae Asset Securities · May 12, 2025
All reports for 000100 →

Advertisement

Korean Tickers·Research reference for Korean listed companies.
Prices use KIS quote snapshots with data.go.kr daily fallback. Financials use DART; macro data uses ECOS.·Market data is informational and not investment advice.
KIS snapshots are refreshed every 30 minutes and are not a streaming quote feed.·Sources
TermsRefundsDisclaimerPrivacy